Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2012-13 | Page 91

### 29. Other Income

Amount in Taka

This is arrived at as follows :

| Particulars | Note | 2013 | 2012 |
|---|---|---|---|
| Interest on FDR & Short term Investment | | 512,424,678 | 437,201,038 |
| Dividend Income | | 3,141,501 | 456,945 |
| Royalty | | 7,785,736 | 3,499,537 |
| Exchange Rate Fluctuation Gain / (Loss)* | | (17,198,454) | (1,055,025) |
| Profit on Sale of Fixed Assets (Note 35) | | 4,434,739 | 2,745,218 |
| **Total** | | **510,588,200** | **442,847,713** |

* This includes loss of Tk. 10,500,000 arising from conversion of foreign currency loan at prevailing exchange rate on the date of Statement of Financial Position.

### 30. Finance Cost

This is arrived at as follows :

| Particulars | Note | 2013 | 2012 |
|---|---|---|---|
| Interest on Working Capital Loan | | 256,763,094 | 252,076,640 |
| Interest on Project / Consortium Loan | | 219,205,840 | 235,182,666 |
| Interest on Lease Finance | | 51,362,542 | 48,268,802 |
| Interest on Loan from PF, WPPF & Welfare Fund | | 81,687,639 | 77,425,824 |
| Other Bank Charges | | 27,567,975 | 32,452,643 |
| **Total** | | **636,587,090** | **645,406,575** |

### 31. Contribution To WPPF & Welfare Funds

This represents statutory contribution by the company as per Bangladesh Labour (amendment) Act 2013. The amount is computed @ 5% of net profit before tax (but after charging such contribution).

### 32. Income Tax Expenses

This consists of as follows :

| Particulars | Note | 2013 | 2012 |
|---|---|---|---|
| **(a) Current Tax :** | | | |
| (i) Tax provision for current year (Note 3.9) | | 305,845,595 | 334,871,966 |
| (ii) Short provision for earlier year | | 18,569,951 | 110,840,941 |
| **Subtotal** | | **324,415,546** | **445,712,907** |
| **(b) Deferred Tax Expense (Note 3.9)** | | **364,415,845** | **144,727,001** |
| **Total** | | **688,831,391** | **590,439,908** |

### 33. Earnings Per Share (EPS)

| Particulars | Note | 2013 | 2012 |
|---|---|---|---|
| (a) Earnings attributable to the Ordinary Shareholders (Tk.) | | 1,404,762,780 | 1,319,389,328 |
| (b) Weighted average number of Ordinary Shares outstanding during the year (Nos.) | | 350,334,907 | 350,334,907 |
| **Earnings Per Share (EPS) / Adjusted EPS (2012) (Tk.)** | | **4.01** | **3.77** |